scholarly journals Gastric adenocarcinoma at stage IV with complete remission after neoadjuvant therapy concurrent with adenosquamous carcinoma of the ampulla of Vater: a case report and literature review

BMC Surgery ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Shuo Li ◽  
Mengqing Sun ◽  
Yingxin Wei ◽  
Yunlu Feng ◽  
Xiaoyan Chang ◽  
...  

Abstract Background Adenosquamous carcinoma (ASC) of the ampulla of Vater (AmV) is exceedingly rare with more aggressive behavior and worse prognosis than adenocarcinoma. The finding of ASC at the AmV in combination to the gastric adenocarcinoma has never been reported in the literature before. Case presentation An old lady was diagnosed as gastric adenocarcinoma at stage IV with enlargement of supraclavicular lymph nodes by gastroscopy and histopathological evaluation 3 years ago. Afterwards, the patient achieved complete remission after regular chemotherapy. However, the patient manifested yellow sclera and skin, choluria and clay colored stool 3 months ago. Preoperative contrast-enhanced CT, ERCP, MRCP, and PET/CT revealed the presence of an ampullary tumor. The patient then underwent laparoscopic radical gastrectomy and pancreaticoduodenectomy with regional lymph node dissection. Postoperative cytological analyses confirmed the diagnosis of gastric ulcer with complete response to neoadjuvant therapy and ASC at the AmV. The patient’s postoperative outcome was uneventful. Conclusion Drawing firm conclusions about the diagnosis of ampullary ASC is difficult because of the difficulty in acquiring both adenocarcinoma and SCC components by fine needle biopsy. The rarity of ASC of the AmV coexistent with gastric carcinoma makes it difficult to elucidate their clinicopathological characteristics, therapeutic strategies and overall prognosis. Surgical resection still remains the main treatment method.

2013 ◽  
Vol 14 (1) ◽  
pp. 20-23 ◽  
Author(s):  
Orestis Ioannidis ◽  
Argiro Sekouli ◽  
George Paraskevas ◽  
Nikolaos Papadimitriou ◽  
Athina Konstantara ◽  
...  

F1000Research ◽  
2012 ◽  
Vol 1 ◽  
pp. 34
Author(s):  
Andreas Diel ◽  
Ernst Rodermann ◽  
Hans-Friedrich Kienzle ◽  
Denis Meuthen ◽  
Ingo Meuthen

A 39-year old patient with gastric adenocarcinoma stage IV failed to respond to preoperative chemotherapies containing 5-FU and cisplatin as well as 5-FU and irinotecan. After third-line chemotherapy with two cycles of docetaxel and cisplatin we confirmed a clinical partial response. A complete histologically confirmed remission was detected after complete resection of the tumor. Following two postoperative cycles of docetaxel and cisplatin, the tumor is still in complete remission after more than eight years.


Diagnostics ◽  
2021 ◽  
Vol 11 (7) ◽  
pp. 1198
Author(s):  
Jean-Baptiste Le Goubey ◽  
Charline Lasnon ◽  
Ines Nakouri ◽  
Laure Césaire ◽  
Michel de Pontville ◽  
...  

Aim: To perform a comprehensive analysis of discordances between contrast-enhanced CT (ceCT) and 18F-FDG PET/CT in the evaluation of the extra-cerebral treatment monitoring in patients with stage IV melanoma. Materials and methods: We conducted a retrospective monocentric observational study over a 3-year period in patients referred for 18F-FDG PET/CT and ceCT in the framework of therapy monitoring of immune checkpoint (ICIs) as of January 2017. Imaging reports were analyzed by two physicians in consensus. The anatomical site responsible for discordances, as well as induced changes in treatment were noted. Results: Eighty patients were included and 195 pairs of scans analyzed. Overall, discordances occurred in 65 cases (33%). Eighty percent of the discordances (52/65) were due to 18F-FDG PET/CT scans upstaging the patient. Amongst these discordances, 17/52 (33%) led to change in patient’s management, the most frequent being radiotherapy of a progressing site. ceCT represented 13/65 (20%) of discordances and induced changes in patients’ management in 2/13 cases (15%). The most frequent anatomical site involved was subcutaneous for 18F-FDG PET/CT findings and lung or liver for ceCT. Conclusions: Treatment monitoring with 18F-FDG PET/CT is more efficient than ceCT and has a greater impact in patient’s management.


Medicine ◽  
2016 ◽  
Vol 95 (35) ◽  
pp. e4389 ◽  
Author(s):  
Li Gao ◽  
Jian Hao ◽  
Yang-Yang Niu ◽  
Miao Tian ◽  
Xue Yang ◽  
...  

2016 ◽  
Vol 16 (2) ◽  
pp. 115 ◽  
Author(s):  
Ch'angbum Rim ◽  
Jung-Ae Lee ◽  
Soojung Gong ◽  
Dong Wook Kang ◽  
Heebum Yang ◽  
...  

2014 ◽  
Vol 2014 ◽  
pp. 1-5
Author(s):  
Sahar Eivaz-Mohammadi ◽  
Fernando Gonzalez-Ibarra ◽  
Waheed Abdul ◽  
Omer Tarar ◽  
Khurram Malik ◽  
...  

A 25-year-old Hispanic female with a history of anemia, schizoaffective disorder, and psychosis was admitted for anemia associated with fatigue, weakness, shortness of breath, night sweats, weight loss, and abdominal and lower back pain for the past two months. On routine management, she was found to have a positive serum b-HCG of 80.4 (0–5 mIU/mL) but the patient denied any sexual activity in her life. During her admission, U/S of the pelvis was noncontributory. CT angiogram of the chest was significant for prominent mediastinal and hilar lymph nodes, diffusely thickened stomach suggesting gastric malignancy with multiple hypoenhancing lesions in the liver and diffuse lytic lesions in the spine and sacrum suspicious for metastatic disease. The MRI of the abdomen confirmed the CT angiogram findings. After these findings, EGD was performed which showed lesions in the antrum, body of the stomach, fundus, and cardia on the lesser curvature of the stomach body correlating with carcinoma. The biopsy was positive for Her2, b-HCG producing poorly differentiated gastric adenocarcinoma. Patient underwent one successful round of chemotherapy with Taxotene, Cisplatin, and 5-FU for Stage IV gastric adenocarcinoma.


2005 ◽  
Vol 35 (9) ◽  
pp. 507-513 ◽  
Author(s):  
Ugo Bottoni ◽  
Paola Bonaccorsi ◽  
Valeria Devirgiliis ◽  
Vincenzo Panasiti ◽  
Riccardo Giovanni Borroni ◽  
...  

2003 ◽  
Vol 11 (1-2) ◽  
pp. 169-181 ◽  
Author(s):  
Masaya Mukai ◽  
Tomoya Hinoki ◽  
Takayuki Tajima ◽  
Hisao Nakasaki ◽  
Shinkichi Sato ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document